Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 36, 2024 - Issue 3
91
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Women’s motivations for participating in the dapivirine vaginal ring open label extension study

, ORCID Icon, ORCID Icon, , &
Pages 326-342 | Received 27 Sep 2022, Accepted 12 Sep 2023, Published online: 21 Sep 2023

References

  • Almeida, L., Azevedo, B., Nunes, T., Vaz-da-Silva, M., & Soares-da-Silva, P. (2007). Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology, 63(11), 1085–1094. https://doi.org/10.1007/s00228-007-0368-3
  • Atieno, S. (2022, June 13). Hiv: Africa gearing towards deployment of vaginal ring. Science Africa. https://scienceafrica.co.ke/2022/06/13/hiv-africa-gearing-towards-deployment-of-vaginal-ring/.
  • Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., Siva, S., Bekker, L.-G., Jeenarain, N., Gaffoor, Z., Martinson, F., Makanani, B., Pather, A., Naidoo, L., Husnik, M., … Hillier, S. (2016). Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New England Journal of Medicine, 375(22), 2121–2132. https://doi.org/10.1056/NEJMoa1506110
  • Baeten, J. M., Palanee-Phillips, T., Mgodi, N. M., Mayo, A. J., Szydlo, D. W., Ramjee, G., Gati Mirembe, B., Mhlanga, F., Hunidzarira, P., Mansoor, L. E., Siva, S., Govender, V., Makanani, B., Naidoo, L., Singh, N., Nair, G., Chinula, L., Parikh, U. M., Mellors, J. W., … Brown, E. R.., MTN-025/HOPE Study Team (2021). Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet. HIV, 8(2), e87–e95. https://doi.org/10.1016/S2352-3018(20)30304-0
  • Bentley, J. P., & Thacker, P. G. (2004). The influence of risk and monetary payment on the research participation decision making process. Journal of Medical Ethics, 30(3), 293–298. https://doi.org/10.1136/jme.2002.001594
  • Colfax, G., Buchbinder, S., Vamshidar, G., Celum, C., McKirnan, D., Neidig, J., Koblin, B., Gurwith, M., & Bartholow, B. (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes (1999), 39(3), 359–364. https://doi.org/10.1097/01.qai.0000152039.88422.ec
  • Dainesi, S. M., & Goldbaum, M. (2011). Provision of investigational drug after clinical research: review of literature, national and international guidelines. Revista da Associacao Medica Brasileira (1992), 57(6), 710–716. https://doi.org/10.1590/S0104-42302011000600021
  • Dhalla, S., & Poole, G. (2011). Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care, 23(11), 1430–1447. https://doi.org/10.1080/09540121.2011.555750
  • Dubé, K., Perry, K. E., Mathur, K., Lo, M., Javadi, S. S., Patel, H., Concha-Garcia, S., Taylor, J., Kaytes, A., Dee, L., Campbell, D., Kanazawa, J., Smith, D., Gianella, S., Auerbach, J. D., Saberi, P., & Sauceda, J. A. (2020). Altruism: Scoping review of the literature and future directions for HIV cure-related research. Journal of Virus Eradication, 6(4), 100008. https://doi.org/10.1016/j.jve.2020.100008
  • Emanuel, E. J., Currie, X. E., Herman, A., & Phidisa, P. (2005). Undue inducement in clinical research in developing countries: is it a worry? Lancet (London, England), 366(9482), 336–340. https://doi.org/10.1016/S0140-6736(05)66992-9
  • Fokazi S. (2022, March 16). More HIV prevention options for SA women as vaginal ring is approved. Timeslive. https://www.timeslive.co.za/news/south-africa/2022-03-16-more-hiv-prevention-options-for-sa-women-as-vaginal-ring-approved/
  • Gold, O. P., & John, E. U. (2013). Accelerating empowerment for sustainable development: The need for health systems strengthening in Sub-Saharan Africa. American Journal of Public Health Research, 1(7), 152–158. https://doi.org/10.12691/ajphr-1-7-2
  • Haire, B. G., & Ogundokun, O. (2014). Ethics of ancillary care in clinical trials in low income countries: a Nigerian case study. African Journal of Reproductive Health, 18(3 Spec No), 135–142.
  • Halpern, S. D., Karlawish, J. H., Casarett, D., Berlin, J. A., & Asch, D. A. (2004). Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Archives of Internal Medicine, 164(7), 801–803. https://doi.org/10.1001/archinte.164.7.801
  • Hlongwa, M., Peltzer, K., & Hlongwana, K. (2020). Risky sexual behaviours among women of reproductive age in a high HIV burdened township in KwaZulu-Natal, South Africa. BMC Infectious Diseases, 20(1), 1–9. https://doi.org/10.1186/s12879-020-05302-1
  • Katz, A., Mensch, B. S., Woeber, K., Musara, P., Etima, J., & van der Straten, A. (2019). Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence. BMC Women's Health, 19(1), 18. https://doi.org/10.1186/s12905-019-0713-6
  • Mash, R., Mash, B., & de Villiers, P. (2010). ‘Why don’t you just use a condom?’: Understanding the motivational tensions in the minds of South African women. African Journal of Primary Health Care & Family Medicine, 2(1), 4. https://doi.org/10.4102/phcfm.v2i1.79
  • Mfutso-Bengo, J., Ndebele, P., Jumbe, V., Mkunthi, M., Masiye, F., Molyneux, S., & Molyneux, M. (2008). Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi. Malawi Medical Journal: The Journal of Medical Association of Malawi, 20(2), 37–41. https://doi.org/10.4314/mmj.v20i2.10898
  • Mngadi, K. T., Frohlich, J., Montague, C., Singh, J., Nkomonde, N., Mvandaba, N., Ntombeka, F., Luthuli, L., Abdool Karim, Q., & Mansoor, L. (2015). Challenges with participant reimbursement: experiences from a post-trial access study. Journal of Medical Ethics, 41(11), 909–913. https://doi.org/10.1136/medethics-2013-101899
  • Mngadi, K. T., Singh, J. A., Mansoor, L. E., & Wassenaar, D. R. (2017). Undue inducement: a case study in CAPRISA 008. Journal of Medical Ethics, 43(12), 824–828. https://doi.org/10.1136/medethics-2016-103414
  • Montgomery, E. T., Katz, A., Duby, Z., Mansoor, L. E., Morar, N. S., Naidoo, K., Tsidya, M., Chitukuta, M., Guma, V., Tenza, S., Leslie, J., Garcia, M., & Naidoo, S. (2021). Men's sexual experiences with the dapivirine vaginal ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS and Behavior, 25(6), 1890–1900. https://doi.org/10.1007/s10461-020-03119-2
  • Montgomery, E. T., Stadler, J., Naidoo, S., Katz, A., Laborde, N., Garcia, M., Reddy, K., Mansoor, L. E., Etima, J., Zimba, C., Chitukuta, M., & Soto-Torres, L. (2018). Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS (London, England), 32(11), 1517–1525. https://doi.org/10.1097/QAD.0000000000001868
  • Naidoo, K., Mansoor, L. E., Katz, A., Garcia, M., Kemigisha, D., Morar, N. S., Zimba, C. C., Chitukuta, M., Reddy, K., Soto-Torres, L., Naidoo, S., & Montgomery, E. T. (2021). Qualitative perceptions of dapivirine VR adherence and drug level feedback following an open-label extension trial. Journal of Acquired Immune Deficiency Syndromes (1999), 86(4), e90–e96. https://doi.org/10.1097/QAI.0000000000002590
  • Nel, A., van Niekerk, N., Kapiga, S., Bekker, L. G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., Miti, N., Kusemererwa, S., Tempelman, H., Carstens, H., Devlin, B., Isaacs, M., Malherbe, M., Mans, W., Nuttall, J., … Rosenberg, Z., Ring Study Team (2016). Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. New England Journal of Medicine, 375(22), 2133–2143. https://doi.org/10.1056/NEJMoa1602046
  • Nel, A., van Niekerk, N., Van Baelen, B., Malherbe, M., Mans, W., Carter, A., Steytler, J., van der Ryst, E., Craig, C., Louw, C., Gwetu, T., Mabude, Z., Kotze, P., Moraba, R., Tempelman, H., Gill, K., Kusemererwa, S., Bekker, L. G., Devlin, B., & Rosenberg, Z., DREAM Study Team (2021). Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV, 8(2), e77–e86. https://doi.org/10.1016/S2352-3018(20)30300-3
  • Psaros, C., Milford, C., Smit, J. A., Greener, L., Mosery, N., Matthews, L. T., Harrison, A., Gordon, J. R., Mimiaga, M., Bangsberg, D. R., & Safren, S. A. (2018). Hiv prevention Among young women in South Africa: Understanding multiple layers of risk. Archives of Sexual Behavior, 47(7), 1969–1982. https://doi.org/10.1007/s10508-017-1056-8
  • Sullivan, K., Mtande, T., Jaffe, E., Rosenberg, N., Zimba, C., Hoffman, I., Little, M., Faden, R., & Lyerly, A. D. (2020). Views among Malawian women about joining HIV prevention clinical trials when pregnant. AIDS Research and Therapy, 17(1), 27. https://doi.org/10.1186/s12981-020-00271-6
  • UNAIDS Data. (2021). Geneva: Joint United Nations Programme on HIV/AIDS. https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf.
  • Warren, E. A., Paterson, P., Schulz, W. S., Lees, S., Eakle, R., Stadler, J., & Larson, H. J. (2018). Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review. PloS one, 13(6), e0198680. https://doi.org/10.1371/journal.pone.0198680

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.